EverSource Wealth Advisors LLC increased its position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 79.8% during the 4th quarter, Holdings Channel reports. The institutional investor owned ...

Hologic HOLX is currently trading at a forward ... The segment’s product revenues plunged 38% in fiscal 2024 due to a temporary halt in Horizon DXA shipments caused by a non-conformance matter ...

Hologic, Inc. engages in the development ... The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and ...

Hologic, Inc. reported adjusted earnings per ... the guidance incorporates the expected impact from the ongoing temporary stop-ship of Horizon DXA systems in Skeletal Health.

Hologic operates in a dynamic industry subject to regulatory changes and shifting market demands. One significant factor on the horizon is the potential change to United States Preventive Services ...

Hologic, Inc. (NASDAQ:HOLX – Get Free Report)’s stock price hit a new 52-week low during trading on Tuesday after Citigroup lowered their price target on the stock from $80.00 to $70.00. Citigroup ...

Hologic (HOLX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Hologic (HOLX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Hologic (HOLX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.